INVA vs TFX: fair value comparison
Innoviva, Inc. and Teleflex Incorporated · Updated 2026-09-06
INVA currently screens as fairly valued while TFX screens as undervalued. Within Healthcare, TFX currently sits closer to the top of our discount ranking. INVA carries the stronger quality grade.
| INVA | TFX | |
|---|---|---|
| Verdict | Fairly valued | Undervalued |
| Last price | $20.77 | $141.56 |
| 12-month range | $18.11–$23.41 | $103.36–$140.48 |
| Sector rank | #60 of 113 Healthcare | #56 of 113 Healthcare |
| Quality grade | B | D |
| Leverage | Low | Low |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | — |
| DCF cross-check | — | Overvalued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: INVA fair value analysis · TFX fair value analysis